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Abstract
Background: Neuropeptide Y is a key neurotransmitter of the central nervous system which
plays a vital role in the feed energy homeostasis in mammals. Mutations in the regulatory and coding
regions of the bovine NPY gene can potentially affect the neuronal regulation of appetite and feeding
behaviour in cattle. The objectives of this experiment were to: a) fully characterize the bovine NPY
gene transcript and b) identify the SNP diversity in both coding and non-coding regions of the NPY
gene in a panel of Bos taurus and B. indicus cattle.
Results: Bovine NPY gene consists of four exons (99, 188, 81 and 195 nucleotides) and three
introns. The promoter region of the NPY  gene consists of TATA and GC boxes which are
separated from the transcription start site (TSS) by 29 and ~100 nt, respectively. Analyses of the
tissue specific expression of the bovine NPY gene revealed the presence of highly abundant NPY
gene transcripts in the arcuate nucleus, cerebral and cerebellar regions of the bovine brain. We
identified a total of 59 SNPs in the 8.4 kb region of the bovine NPY gene. Seven out of nine total
SNPs in the promoter region affect binding of putative transcription factors. A high level of
nucleotide diversity was evident in the promoter regions (2.84 × 10-3) compared to the exonic
(1.44 × 10-3), intronic (1.30 × 10-3) and 3' untranslated (1.26 × 10-3) regions.
Conclusion: The SNPs identified in different regions of bovine NPY gene may serve as a basis for
understanding the regulation of the expression of the bovine NPY  gene under a variety of
physiological conditions and identification of genotypes with high feed energy conversion efficiency.
Background
Following concerns that methane emissions from rumi-
nants are contributing to global warming, there is an
increased demand for the development of sustainable
agricultural production systems [1,2]. One component of
such systems is the ability to be able to genetically select
animals that can efficiently utilize feed energy [3,4]. This
requires an understanding of the underlying genomic fac-
tors influencing energy conversion efficiency in rumi-
nants. Neuropeptide Y, a key neurotransmitter of the
central nervous system which plays a vital role in the feed
energy homeostasis in mammals, has the potential to
serve as a candidate for the energy conversion in rumi-
nants. Expression of the neuropeptide Y (NPY) gene is
considered to be a regulator of feed intake in cattle [5].
Neuropeptide Y influences a number of biological path-
ways regulating appetite, feeding behavior and energy
homoeostasis in humans and animals [6-9]. Neuropep-
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tide Y was found to stimulate growth hormone secretion
in cattle [10], to increase the expression of the leptin gene
[11] in sheep, and to decrease free fatty acid secretion in
adipocyte cell lines [12].
In cattle, the NPY gene is mapped to chromosome 4 [13].
The NPY gene codes for a functional peptide of 36 amino
acid residues. This peptide is highly conserved across the
mammalian species further indicating the physiological
importance of the neuropeptide Y molecule [14]. It is
likely that because of evolutionary conservation, the NPY
gene harbors useful genetic variation in the regulatory
regions [15]. To identify the promoter region and to dis-
tinguish between the coding and non-coding regions of
the gene, it is important that the transcription start site
(TSS) be accurately identified [16]. In silico identification
of the TSS through computational methods is feasible, but
such methods need further experimental verification [17].
A comparative genomic analysis, combined with the
sequence information derived from the full length cDNA
is identified as a technique of identification of the TSS
[18-20].
Three SNPs were previously identified in the intronic
regions of the bovine NPY gene [13]. However, currently
no information is available on the extent of genetic diver-
sity present in the promoter and exonic regions of the
bovine NPY gene. SNPs in the promoter region may affect
binding of transcription factors and thus influence the
expression of the NPY gene. Hence, the objectives of this
experiment were to: a) fully characterize the bovine NPY
gene transcript and b) identify the SNP diversity in both
coding and non-coding regions of the NPY gene in a panel
of Bos taurus and B. indicus cattle.
Results
In silico comparative sequence analysis of NPY gene
The NCBI/Ensemble available 5' untranslated region and
the first available exon of the bovine NPY  gene
[GeneBank: AY491054] were compared to the ortholo-
gous sequences from the horse [Ensembl: ENSECAG0000
0008726], mouse [Ensembl: ENSMUSG00000029819],
rat [Ensembl: ENSRNOG00000009768], dog [Ensembl:
ENSCAFG00000002801] and human [Ensemble:
ENSG00000122585]. Comparative sequence analysis
revealed highly conserved sequences among the mamma-
lian species with 100% homology in a GC rich
(GGGGCGGG) region and an AT rich (ATAAAA) region.
These two regions most likely represent the GC box and
TATA box components of the core promoter of the mam-
malian NPY gene.
However, a discrepancy was identified in the naming of
the exons. Exon 1 of the horse, mouse and human, corre-
sponded to a section of the 5' untranslated region (UTR)
in the bovine sequence. The first exon reported in the
NCBI bovine sequence was 1056 nucleotides (nt) down-
stream from the TATA box. As the core promoter sequence
(TATA box) of a typical TATA driven mammalian gene is
generally located about 26 to 31 nt upstream of the TSS
[21], we sought to verify the presence of an additional cur-
rently unidentified exon containing the TSS in the bovine.
Identification of exon 1 and the TSS of the bovine NPY 
gene
Analysis of the sequence data from full length cDNA
[GeneBank: EU935419] from the arcuate nucleus, cere-
bral, and cerebellar regions of the brain revealed that the
TSS of the bovine NPY gene (comprised of an ACC site)
was located 29 nt downstream of the ATAAAA motif (rel-
ative to the T). Identification of the TSS confirms that a
previously unidentified exon is present in the bovine NPY
gene. Comparative sequence analysis of full length cDNA
with the NCBI available DNA sequences from the horse,
mouse, rat, dog and human identified this exon (99 nt
length) as exon 1 in the bovine (Figure 1). This confirms
that the bovine NPY gene consists of four exons (total
cDNA length 563 nt) and three introns (Figure 2).
Variation in the expression of NPY gene in different tissues
The expression of the bovine NPY gene was investigated in
the arcuate nucleus, cerebral and cerebellar regions of the
brain, subcutaneous adipose tissue, Longissimus dorsi mus-
cle, liver and small intestine. As demonstrated by the qual-
itative gene expression analysis by RT-PCR, the mRNA of
the bovine NPY gene was present in the arcuate nucleus,
cerebral and cerebellar regions of the brain, subcutaneous
adipose tissue, L. dorsi muscle and small intestine and
absent in the liver (data not shown). However, the quan-
titative real time RT-PCR revealed that the relative abun-
dance of the NPY gene transcript (normalized against the
GAPDH gene), were high in the brain tissues, low in the
subcutaneous adipose tissue and small intestine and neg-
ligible in the L. dorsi muscle (Figure 3).
SNPs in the promoter region of the bovine NPY gene
The SNPs identified were positioned based on the identi-
fication of the TSS. Nine SNPs were identified in a 639 nt
segment of the promoter region of the bovine NPY gene
(Table 1). The nucleotide diversity in this region was cal-
culated to be 2.84 × 10-3. Of these SNPs, four (-20, -122, -
124 and -347) were unique to B. taurus and one (-31) was
unique to B. indicus. Four SNPs (-190, -257, -324 and -
520) were common to both species. At loci -257 and -190,
A and T were the major alleles in B. taurus whereas in these
two loci C was the major allele in B. indicus. Two C inser-
tions, at -122 and -124 were present in one Limousin ani-
mal. Using EM algorithm a total of 15 haplotypes were
identified from the pooled datasets from B. taurus and B.
indicus  samples and the haplotypes diversity presented
(Figure 4).BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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The promoter sequence of the bovine NPY  gene was
screened for the identification of different putative tran-
scription factor binding sites (TFBS). In the 639 nt pro-
moter region examined, a total of 61 TFBS bindings were
predicted (core similarity >80% and matrix similarity
>85%, both strands) which included TFBS from 51 differ-
ent transcription factor families (data not shown). SNPs at
loci -20, -31, -122, -124, -257, -324 and -347 affect 15
putative TFBS (Table 2). Of the total 9 SNPs identified in
the promoter region of the bovine NPY gene, the SNPs at
-20 and -31 are very interesting since they are present in
the core promoter region (TATA box). These two SNPs are
most likely to affect the binding of the TATA-binding pro-
tein factor and autoimmune regulatory element binding
factor.
SNPs in the exonic, intronic and 3' UTR of the bovine NPY 
gene
In the 563 nt exonic region (total 4 exons) of the bovine
NPY gene, a total of four SNPs were identified (Table 3).
The nucleotide diversity in the exonic regions was calcu-
lated to be 1.44 × 10-3. The SNPs at +1100 (B. taurus) and
+1106 (B. indicus) were present in exon 2. However, as
deduced from the amino acid sequence of the NPY pep-
tide, no amino acid changes occur due to any of these
SNPs. Two exonic SNPs were also present at +6751 (B. tau-
rus) and +6887 (B. indicus) in exon 4. These variants are
located in the untranslated region of the mRNA transcript
which might have regulatory role.
A total of forty one SNPs were identified in the 6358 nt
region across the three introns (Table 3). Thirteen SNPs
were identified in intron 1 (929 nt), fifteen in intron 2
(3638 nt) and thirteen in intron 3 (1790 nt). The overall
nucleotide diversity in the intronic regions was 1.30 × 10-
3. A total of five SNPs were also identified in the 3' UTR
(801 nt) of the bovine NPY gene (Table 3) which gave rise
to a nucleotide diversity value of 1.26 × 10-3.
Discussion
Following a combined approach of full length cDNA anal-
yses, genomic DNA sequencing and evolutionary genom-
ics, we characterised the bovine NPY gene transcript. We
identified one previously unidentified exon of the bovine
Comparative sequence analyses of the promoter region of the NPY gene in mammalian species Figure 1
Comparative sequence analyses of the promoter region of the NPY gene in mammalian species. The conserved 
TATA and GC boxes (highlighted in yellow), transcription start sites and the available exon1 (in lower case) are shown.BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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NPY gene and mapped the TSS and various coding and
non-coding regions of the NPY gene transcript. Analyses
of the tissue specific expression of the bovine NPY gene
revealed the presence of highly abundant NPY gene tran-
scripts in the arcuate nucleus, cerebral and cerebellar
regions of the bovine brain. We sequenced a total of 8361
nt genomic region which included the coding and non-
coding regions of the gene and identified a total of 59
SNPs. A high level of nucleotide diversity was evident in
the promoter region compared to the exonic, intronic and
3' UTR.
Based on the in silico analyses of the NPY gene sequences
from horse, mouse, rat, dog and human, we identified the
core promoter of the bovine NPY gene. Our results sug-
gested that the conserved ATAAAA region of the NPY gene
is the TATA element. The TATA element serves as a bind-
ing site for the TATA binding protein (TBP), an important
transcription factor which plays a key role in the transcrip-
tional activity of the RNA polymerase II enzyme [21,22].
We also identified another interesting conserved GC rich
region (GGGGCGGG) as the GC box element of the NPY
promoter. The mammalian GC box element is the TFBS of
SP1 which initiates transcription [23-25]. The TATA and
the GC elements are separated from the TSS by 29 nt and
~100 nt, respectively, which is typical for any TATA con-
taining mammalian gene [21]. The previously reported
TATA elements of the NPY gene of chicken (TTAAAA) [14]
and Chinese perch (ATAAAA) [26] were very similar to the
TATA element of the mammals identified in this experi-
ment. The TSS of the bovine NPY gene (ACC) is similar to
the previously characterised TSS of the human [27].
We identified an extra exon of the bovine NPY gene (99 nt
length) which was previously uncharacterized. In the
NCBI/Ensemble databases, this exon was designated in
the horse, mouse and human NPY gene sequences. This
exon is located outside the region that translates into the
core peptide of 36 amino acids. As in most eukaryotic
genes, the region corresponding to the first exon in the
mRNA transcript is likely to play a regulatory role in the
translation of the NPY mRNA [28]. The first exon provides
the initial binding site for the 40S ribosomal unit which is
required to start the translation at an AUG codon of the
reading frame [28]. To have an efficient translation at the
AUG codon, the first exon must have an A at three nt
upstream of the AUG codon [28,29]. This A was highly
conserved across the mammalian species investigated in
this experiment. The length of the bovine NPY  cDNA
deduced (563 nt, excluding the poly A tail) is in agree-
ment with the previously reported NPY cDNA length of
the human (591 nt, which included the poly A tail) [27].
A high level of expression of the NPY gene was evident in
the arcuate nucleus, cerebral and cerebellar regions of the
brain. As previously demonstrated in the mammalian
Schematic diagram of the bovine NPY gene showing the promoter, exons, introns and 3' regions and their relative sizes and  positions reference to the TSS Figure 2
Schematic diagram of the bovine NPY gene showing the promoter, exons, introns and 3' regions and their rel-
ative sizes and positions reference to the TSS.BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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brain, Neuropeptide Y is widely distributed in the central
nervous system of mammals [30,31]. The availability of
the NPY mRNA transcript in the central nervous system
suggests its central regulation of energy homeostasis.
Among the peripheral tissues, expression of the NPY gene
was also evident in the subcutaneous adipose tissue and
small intestine. Since both subcutaneous adipose tissue
and the mammalian gastrointestinal tract are innervated,
such tissues can also produce neuropeptide Y [26,32].
Recently, mammalian adipose tissue has been identified
as a new site of NPY gene expression and neuropeptide Y
biosynthesis [33,34]. The neuropeptide Y produced in the
brain and that of the peripheral tissue system such as adi-
pose tissues had structural similarity. However, the func-
tional relevance of neuropeptide Y in these tissues needs
more research. Although we did not detect any NPY gene
transcript in the liver tissue and a minor expression the L.
dorsi, availability of neuropeptide Y in the mammalian
skeletal muscle tissue and liver has been previously
reported in the literature [35-37].
We sequenced a 639 nt promoter region and identified
nine novel SNPs of which seven SNPs were affecting TFBS.
Interestingly, the SNPs at -20 (T to G transversion) and -
Relative abundance of bovine NPY gene transcript in the arcuate, cerebrum and cerebellum regions of the brain, subcutaneous  adipose tissue, Longissimus dorsi, liver and small intestine tissues Figure 3
Relative abundance of bovine NPY gene transcript in the arcuate, cerebrum and cerebellum regions of the 
brain, subcutaneous adipose tissue, Longissimus dorsi, liver and small intestine tissues. The mRNA transcripts of 
bovine NPY and GAPDH genes were quantified by the real time reverse transcriptase PCR. The relative quantities of the mRNA 
transcript of bovine NPY gene were normalized against the relative quantities of the GAPDH (housekeeping) gene.
Table 1: Single nucleotide polymorphisms (SNPs) identified in the promoter region of bovine NPY gene and their population statistics.
NCBI dbSNP Accession ss# Locus SNP Bos taurus (n = 34) Bos indicus (n = 6)
Major allele frequency Heterozygous Major allele frequency Heterozygous
107795824 -520 C/A 0.85 (C) 9 0.50 (C) 0
107795825 -347 A/T 0.97 (A) 0 - -
107795826 -324 C/A 0.97 (C) 2 0.50 (C) 1
107795827 -257 A/C 0.95 (A) 1 0.90 (C) 1
107795828 -190 T/C 0.95 (T) 1 0.90 (C) 1
107795829 -124 C/+ 0.97 (C) 0 - -
107795830 -122 C/+ 0.97 (C) 0 - -
107795831 -31 C/+ - - 0.83 (C) 0
107795832 -20 T/G 0.93 (T) 1 - -BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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31 (C addition) are on the TFBS of the TATA binding pro-
tein (TBP) transcription factor. The TATA box of the NPY
gene constitutes the core promoter region which is highly
conserved across the mammalian species and hence, the
SNPs at -20 and -31 are likely to play vital roles in the
expression of the bovine NPY gene. Other mutations iden-
tified in the promoter region of the bovine NPY gene are
also likely to affect the expression of the gene and conse-
quently the amount of Neuropeptide Y synthesised. It has
potential consequences for feed energy conversion and
energy homeostasis in the bovine [38,39]. The haplotypes
derived from the SNPs in the promoter region of the
bovine NPY gene will serve as a basis for developing in
vitro assays for investigating the role of the promoter SNPs
in the regulation of the expression of the bovine NPY
gene.
Among the four exonic SNPs reported, two exonic SNPs
are synonymous and the other two SNPs located in the
untranslated region might have a mostly regulatory func-
tion which needs further investigation. Among the total
59 SNPs identified in the coding and non-coding regions
of the bovine NPY  gene, three intronic SNPs (+1312,
+1694 and +4066) were previously reported [13] and the
genetic association of two of these SNPs were recently
investigated in beef cattle [5].
Noticeably high nucleotide diversity in the promoter
region compared to the exonic, intronic and 3' (UTR)
regions of the bovine NPY gene observed could serve as a
source of genetic variation necessary for the evolutionary
adaptation of animals [40]. Since neuropeptide Y is highly
conserved during the evolutionary processes, SNPs caus-
ing any alteration of the core peptide is probably undesir-
able [15]. Therefore, the promoter region of the gene is
likely to contain more genetic variation for evolutionary
adaptation compared to the other regions [15,41].
Although most of the SNPs identified were in the intronic
regions, the overall nucleotide diversity in the introns was
less than that of the promoter region.
Conclusion
Characterization of the gene transcript, especially identifi-
cation of the correct promoter region (cis acting element)
and TSS, is a requisite for understanding the regulation of
gene expression and underlying effects of genetic variation
[16]. We systematically characterized the bovine NPY
gene transcripts and mapped the promoter, TSS and the
exons and intron regions. This will serve as a basis for
investigating the regulatory role of the SNPs in the expres-
sion of the bovine NPY gene and identification of geno-
types with high feed energy conversion efficiency. The
extra exon reported may likely play an important role as a
regulatory sequence of gene expression [16]. The SNPs
and the haplotypes identified in the bovine NPY  gene
could be targeted for further functional verification and
investigating their association with feed intake in cattle in
particular, and understanding the physiological role
played by the neuropeptide Y in energy homeostasis in
mammals, in general.
Methods
Tissue samples and RNA extraction
Tissue samples (2 g each) from bovine brain (arcuate
nucleus, cerebral and cerebellar regions), subcutaneous
adipose tissue, Longissimus dorsi muscle, liver and small
Diversity of the haplotypes based on the occurrence of SNPs  in the promoter region of the NPY gene in the Bos taurus and  B. indicus cattle Figure 4
Diversity of the haplotypes based on the occurrence 
of SNPs in the promoter region of the NPY gene in 
the Bos taurus and B. indicus cattle. The major haplo-
types (H1, H2, H3, H5, H6, H7, H9, H10 and H15) are indi-
cated by the circle proportional to the haplotype frequency 
and separated by the SNP loci differing between the haplo-
types.BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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intestine were surgically removed and collected in RNA
later™ (Ambion, Inc. Austin, TX). Total RNA was extracted
from 50 mg of the bovine tissue using TRI Reagent®
(Molecular Research Centre, Inc. USA) according to the
manufacturer's instructions. The RNA was dissolved in 20
μl of 0.1% DEPC treated water and then subjected to
deoxyribonuclease I (DNase I) treatment (Qiagen, Chats-
worth, CA, USA). Re-extraction of RNA was carried out
using phenol-chloroform. The RNA pellet was finally dis-
solved in 20 μl of nuclease-free water. The quality and
quantity of the total RNA was evaluated on a 1.2% agarose
gel stained with ethidium bromide and on a NanoDrop®
ND-1000 Spectrophotometer (Thermo Fisher Scientific
Inc. MA, USA), respectively. Samples with a 260/280 ratio
≥ 2.0 were used for further analysis.
Quantitative real time RT-PCR (qRT-PCR)
Initially the cDNA was synthesized using oligo(dT)20
primer with 1.0 μg of total RNA in a final reaction volume
of 20 μl using the Superscript™ III First-strand synthesis
system for reverse transcriptase-polymerase chain reaction
(RT-PCR) (Invitrogen Corp., San Diego, CA, USA). Using
gene specific primers for the bovine NPY gene [GeneBank:
AY491054] (Forward – 5' CGG CTC TCA CCC CTA GAA
3', reverse – 5' TCT GCC TGG TGA TGA GAT 3') and
bovine GAPDH gene [42], the qRT-PCR assay was per-
formed in an ABI 7300 Real-Time PCR system (Applied
Biosystems, Foster City, CA, USA). The reaction was car-
ried out with 0.5 μl cDNA in a 25 μl final reaction volume
with 1 × Power SYBR® Green master mix (Applied Biosys-
tems) and 0.2 μM of each of the forward and reverse prim-
ers. The thermal cycle conditions were 94°C for 30 sec
followed by 60°C for 1 min, for 40 cycles, followed by
dissociation of the product at 96°C for 2 min. The relative
quantities of the NPY gene transcript in different bovine
tissues were normalized against the relative quantities of
the GAPDH gene in those tissues as previously described
[42].
Full length cDNA synthesis and amplification of the 5' and 
3' cDNA regions
Full length cDNA was synthesized from 2.5 μg total RNA
using a GeneRacer™ Kit (Invitrogen Corp.) and following
manufacturer's instructions. Briefly, the total RNA was
dephosphorylated using 10 U of calf intestinal phos-
phatase and followed by removal of the mRNA cap struc-
ture by treating with 0.5 U tobacco acid pyrophosphatase
enzyme. At the final step of RNA modification, an RNA
oligonucleotide adaptor (5' CGA CUG GAG CAC GAG
GAC ACU GAC AUG GAC UGA AGG AGU AGA AA 3')
was ligated to the decapped mRNA using 5 U of T4 RNA
ligase. Every step of RNA modification was followed by a
clean-up step using phenol:chloroform. Full length cDNA
was synthesized from the modified RNA using Super-
script™ III First-strand synthesis system as described ear-
lier. However, instead of the conventional oligo(dT)20
primer used before, GeneRacer Oligo dT primer which has
an anchor sequence (5' GCT GTC AAC GAT ACG CTA
CGT AAC GGC ATG ACA GTG 3') with the oligo (dT)24
was used.
Amplifications of the 5' end of the NPY gene transcript (5'
RACE) were carried out using a combination of the 5'
adaptor primer (5' GGA CAC TGA CAT GGA CTG AAG
GAG TA 3') as a forward primer and a gene specific primer
(sequence as above) as reverse primer. For the amplifica-
tion of the 3' end (3' RACE), the gene specific forward
primer (sequence as above) and 3' adaptor primer (5'
CGC TAC GTA ACG GCA TGA CAG TG 3') were used. The
PCR conditions for both 5' and 3' RACE-PCR were; 94°C
for 2 min followed by forty cycles of denaturation (94°C
for 30 sec), annealing (57°C for 30 sec) and amplification
Table 2: The SNPs in the 639 nt promoter region of bovine NPY gene those affects the putative transcription factors
Putative transcription factors Start End Recognition sequence SNPs
PAX-4/PAX-6 paired domain binding sites -356 -338 gagataggtGCAGcccaga* A/T (-347)
GATA binding factors -348 -336 cagaGATAggtgc* A/T (-347)
Nuclear factor 1 -341 -321 ccggtctagtcctGCCAgaga* C/A (-324)
Vertebrate SMAD family of transcription factors -331 -323 gGTCTagtc* C/A (-324)
E-box binding factors -324 -312 cctCCACgcccgg* C/A (-324)
Nuclear receptor subfamily 2 factors -280 -256 tggaccacgcCAAAgcacaagtttc* A/C (-257)
EGR/nerve growth factor induced protein C & related factors -135 -119 aagggAGGGggtccaga* +C (-122), +C(-124)
EGR/nerve growth factor induced protein C & related factors -133 -117 ataaGGGAgggggtcca* +C (-122), +C(-124)
Pleomorphic adenoma gene -132 -112 GGGGgataagggagggggtcc* +C (-122), +C(-124)
Myc associated zinc fingers -131 -119 aagggaGGGGgtc* +C (-122), +C(-124)
GC-Box factors SP1/GC -131 -117 ataagGGAGggggtc* +C (-122), +C(-124)
Gut-enriched Krueppel like binding factor -128 -116 gataagggaGGGG* +C (-122), +C(-124)
GATA binding factors -124 -112 ggggGATAaggga* +C (-124)
Autoimmune regulatory element binding factor -38 -12 ttgcaacagggtttttaTGGCtctccc* +C (-31), T/G(-20)
Tata-binding protein factor -33 -17 agccaTAAAaaccctgt +C (-31), T/G(-20)
*- minus strandBMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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Table 3: Single nucleotide polymorphisms (SNPs) in the exonic (in bold letters), intronic and 3' regions of bovine neuropeptide Y 
(NPY) gene.
NCBI dbSNP Accession ss# Locus SNP Bos taurus (n = 34) B. indicus (n = 6)
Major allele frequency Heterozygous Major allele frequency Heterozygous
107795833 197 C/G - - 0.83 0
107795834 218 G/C 0.91 0 0.83 0
107795835 228 C/T 0.99 1 0.67 4
107795836 305 C/G 0.93 3 0.92 1
107795837 358 G/A 0.99 1 0.75 3
107795838 361 A/C 0.93 3 0.92 1
107795839 380 G/A - - 0.67 4
107795840 592 C/A 0.99 1 0.67 2
107795841 642 G/A 0.93 3 0.88 1
107795842 762 T/C 0.96 1 0.92 1
107795843 820 G/A 0.97 0 - -
107795844 1004 C/+ - - 0.83 0
107795845 1014 C/T 0.97 2 0.83 0
107795846 1100 C/T 0.99 1 - -
107795847 1106 C/G - - 0.90 1
107795848 1312 A/C 0.75 9 - -
107795849 1321 A/G 0.87 5 - -
107795850 1420 C/A - - 0.90 1
107795851 1541 G/A - - 0.80 2
107795852 1694 A/G 0.57 11 - -
107795853 1713 G/T 0.85 4 - -
107795854 1757 G/A - - 0.80 2
107795855 1865 T/C 0.93 3 - -
107795856 2175 C/T 0.91 4 -
107795857 2551 A/- - - - -
107795858 2892 G/A 0.70 14 - -
107795859 3883 A/- - - - -
107795860 4018 G/A 0.97 0 - -
107795861 4042 G/A - - 0.80 2
107795862 4066 T/C 0.75 9 - -
107795863 4953 G/A 0.96 3 - -
107795864 5213 C/G 0.96 3 - -
107795865 5273 A/G 0.96 3 - -
107795866 5280 T/A 0.96 3 - -
107795867 5642 C/T 0.95 3 0.75 1
107795868 5930 A/G - - 0.83 2
107795869 6341 G/A - - 0.50 4
107795870 6368 T/G 0.95 3 0.75 1
107795871 6385 A/G 0.95 3 0.75 1
107795872 6400 C/T 0.95 3 0.75 1
107795873 6526 A/T 0.98 1 - -
107795874 6527 G/A 0.95 3 - -
107795875 6658 A/C 0.91 4 0.83 2
107795876 6751 T/G 0.99 1 -
107795877 6887 A/T - - 0.83 2
107795878 7192 C/T 0.50 16 - -
107795879 7211 A/T 0.91 4 - -
107795880 7552 T/- 0.88 0 0.80 0
107795881 7553 C/- 0.88 0 0.80 0
107795882 7641 T/G 0.88 2 - -BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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(70°C for 1 min 30 sec). The PCR products were assayed
on a 1.2% agarose gel. The PCR product of the 5' and 3'
RACE-PCR were cloned into a plasmid vector using TOPO
TA cloning® kit (Invitrogen Corp.) following the manufac-
turer's instructions. Sequencing of the plasmid DNA was
carried out in both forward and reverse directions as
described below.
Identification of SNPs in the bovine NPY gene
Animals and genomic DNA preparation
The animals (total n = 40) used for identification of the
SNPs in the bovine NPY gene comprised of unrelated ped-
igree bulls (n = 34) used for performance evaluation by
the Irish Cattle Breeding Federation (ICBF) at the
National Beef Performance Station (NBPS), Tully, Co. Kil-
dare, Ireland and one breed of B. indicus (n = 6) (Table 4).
Blood samples were collected from the jugular vein of the
cattle in BD Vacutainers (Vacutainer Systems, UK) and
stored at -20°C until used for DNA extraction. Genomic
DNA was extracted from 200 μl of blood using GenElute™
Blood Genomic DNA kit (Sigma-Aldrich Corp. St. Louis,
MO, USA) following manufacturer's instructions. At the
final step, the genomic DNA was eluted with 200 μl nucle-
ase free water and store at -20°C. The quality and quantity
of the genomic DNA was assessed on a 0.8% agarose gel
and using a NanoDrop®ND-1000 Spectrophotometer
(Thermo Fisher Scientific Inc.), respectively.
PCR amplification of the genomic region of the bovine NPY gene
The nucleotide sequence of the bovine NPY gene (includ-
ing the 5'and 3' UTR) was obtained from the GeneBank
through alignment of the contig [GeneBank:
NC_007302.1] with the available bovine NPY  gene
sequence [GeneBank: AY491054]. Seven sets of PCR
primers (Table 5) were generated using the web-based
software Primer3 http://primer3.sourceforge.net/ to
amplify a total of 8361 nt genomic region. The primers
were designed in such a way as to provide an overlap of
~100 nt between any two consecutive fragments. PCR
amplification of the different fragments of the bovine
NPY gene was performed in a PTC-225 DNA Engine Tet-
rad (MJ Research, Inc. Massachusetts, USA) with 0.75 μL
of the genomic DNA template in a 50 μl final reaction vol-
ume. The PCR reaction contained 1× PCR buffer, 1.5 mM
MgCl2, 0.2 μM dNTP mix, 0.2 μM each of the forward and
reverse primers and 0.2 unit of Platinum Taq  DNA
polymerase (Invitrogen Corp.). The PCR cycle conditions
were 94°C for 45 sec, 55°C for 45 sec and 72°C for 1.5
min for forty cycles followed by a final extension of 72°C
for 10 min for all fragments.
Sequencing of the genomic/plasmid DNA
For sequencing of the PCR products, 40 μl of the PCR
product was cleaned up using Gen Elute™ PCR clean-up
kit (Sigma-Aldrich Corp.) following the manufacturer's
instructions. The quality and quantity of the purified PCR
product was assessed as described earlier. Using both for-
ward and reverse primer sets, separate sequencing reac-
tions were performed on the clean PCR product (20 ng/
100 bases of DNA to be sequenced). For the plasmid
DNA, 200 ng of the plasmid DNA was sequenced in both
directions using plasmid-specific standard sequencing
primers. Sequencing was performed by MWG-Biotech,
Germany. Sequence data with PHRED quality score >20
(conform the accuracy of >99% of the base called) was
used for multiple sequence comparison and SNP identifi-
cation. SNPs were identified through comparison of the
sequence data from all animals using Molecular Evolu-
tionary Genetic Analysis (MEGA) v 4.0 software [43].
Statistical Analysis
The nucleotide diversity in the promoter, exon, intron and
3' (UTR) regions of the bovine NPY gene was calculated
considering the normalized number of variant sites as pre-
viously described [44,45]. Accordingly, the normalized
number of variant sites
where, 'K' is the observed number of variant sites, 'L' is the
total sequence length and 'n' is the number of chromo-
some sequenced. Basic population statistics including the
allele and genotype frequencies were determined by anal-
ysis of the genotype data using Arlequin 3.11 [46]. The
haplotype analysis was performed using EM algorithm in
the Arlequin software.
θ = −
=
−
∑ Ki L
i
n
/ 1
1
1
Table 4: Breeds of beef cattle used for determination of the 
diversity of SNPs in the coding and non-coding region of bovine 
NPY gene
Species Breed (n)
Bos taurus 34
Limousin 6
Simmental 6
Charolais 5
Aberdeen Angus 4
Hereford 3
Parthenais 3
Salers 3
Aubrac 1
Belgian Blue 1
Blonde d'Aquitaine 1
Shorthorn 1
Bos indicus Local breeds 6
Total 40BMC Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2156/9/91
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